Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Philippines Plans A New Round Of Drug Price Cuts For Branded Products

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - The Philippines' Department of Health is mapping out plans for yet another round of drug price cuts following those imposed in mid-2009 and in early 2010

You may also be interested in...



Aim To Cut Drug Prices By Asian Governments May Backfire, Discourage Investment – IMS

Efforts by Asian governments to reduce drug prices may have little impact on healthcare provision and may in fact backfire by driving some drugs out of the market.

Philippine Drug Price Controls Pinch Brands And Generics

SHANGHAI - State-mandated price cuts in the Philippines on branded drugs are putting some generics makers in a tight spot. The government price controls, which began in August 2009, have spread swiftly, and the caps affecting commonly prescribed drugs are now pressuring their generic competitors

Philippine Drug Price Controls Pinch Brands And Generics

SHANGHAI - State-mandated price cuts in the Philippines on branded drugs are putting some generics makers in a tight spot. The government price controls, which began in August 2009, have spread swiftly, and the caps affecting commonly prescribed drugs are now pressuring their generic competitors

Related Content

UsernamePublicRestriction

Register

SC074350

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel